# The Application of "HUAXI Hole 1" in Reverse-sequence Endoscopic Nipple-sparing Mastectomy With Direct-to-implant Breast Reconstruction

> **NCT06995118** · NA · RECRUITING · sponsor: **Du Zhenggui** · enrollment: 337 (estimated)

## Conditions studied

- Breast Cancer Early Stage Breast Cancer (Stage 1-3)

## Interventions

- **PROCEDURE:** HUAXI hole 1

## Key facts

- **NCT ID:** NCT06995118
- **Lead sponsor:** Du Zhenggui
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-17
- **Primary completion:** 2026-06-01
- **Final completion:** 2031-12-31
- **Target enrollment:** 337 (ESTIMATED)
- **Last updated:** 2025-07-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06995118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06995118, "The Application of "HUAXI Hole 1" in Reverse-sequence Endoscopic Nipple-sparing Mastectomy With Direct-to-implant Breast Reconstruction". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06995118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*